The Efficacy and Safety of Combination of Intravenous and Topical Tranexamic Acid in Revision Hip Arthroplasty: A Randomized, Controlled Trial

Journal of Arthroplasty

Volumn 31, Issue 11, 2016, Pages 2548-2553

  Wu, Yuan gang ^a   Zeng, Yi ^a   Yang, Ti min ^a   Si, Hai bo ^a   Cao, Fei ^a   Shen, Bin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

blood loss; DVT; revision total hip arthroplasty; tranexamic acid; transfusions

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROCNEMIUS MUSCLE; HIP ARTHROPLASTY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPERATIVE BLOOD LOSS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VEIN THROMBOSIS; AGED; ANIMAL; CHEMICALLY INDUCED; COMPARATIVE STUDY; HIP REPLACEMENT; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; MIDDLE AGED; PERIOPERATIVE PERIOD; REOPERATION; STATISTICS AND NUMERICAL DATA; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, TOPICAL; AGED; ANIMALS; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; REOPERATION; TRANEXAMIC ACID; VENOUS THROMBOSIS;

EID: 84966603253     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2016.03.059     Document Type: Article

References (36)

1. 1 Kurtz, S., Ong, K., Lau, E., et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am, 89, 2007, 780.
2. 2 Bridgens, J.P., Evans, C.R., Dobson, P.M., et al. Intraoperative red blood-cell salvage in revision hip surgery. A case-matched study. J Bone Joint Surg Am, 89, 2007, 270.
3. 3 Callaghan, J.J., O'Rourke, M.R., Liu, S.S., Blood management: issues and options. J Arthroplasty, 20, 2005, 51.
4. 4 Kumar, A., Perioperative management of anemia: limits of blood transfusion and alternatives to it. Cleve Clin J Med, 76, 2009, S112.
5. 5 Cardone, D., Klein, A.A., Perioperative blood conservation. Eur J Anaesthesiol, 26, 2009, 722.
6. 6 Madjdpour, C., Spahn, D.R., Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth, 95, 2005, 33.
7. 7 Paul, J.E., Ling, E., Lalonde, C., et al. Deliberate hypotension in orthopedic surgery reduces blood loss and transfusion requirements: a meta-analysis of randomized controlled trials. Can J Anaesth, 54, 2007, 799.
8. 8 Hill, S.R., Carless, P.A., Henry, D.A., et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev(2), 2002, CD002042.
9. 9 Claeys, M.A., Vermeersch, N., Haentjens, P., Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg, 107, 2007, 397.
10. 10 Yamasaki, S., Masuhara, K., Fuji, T., Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases. Int Orthop, 28, 2004, 69.
11. 11 Oremus, K., Sostaric, S., Trkulja, V., et al. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial. Transfusion, 54, 2014, 31.
12. 12 Loftus, T.J., Spratling, L., Stone, B.A., et al. A patient blood management program in prosthetic joint arthroplasty decreases blood use and improves outcomes. J Arthroplasty, 31, 2016, 11.
13. 13 Phillips, S.J., Chavan, R., Porter, M.L., et al. Does salvage and tranexamic acid reduce the need for blood transfusion in revision hip surgery?. J Bone Joint Surg Br, 88, 2006, 1141.
14. 14 Kazi, H.A., Fountain, J.R., Thomas, T.G., et al. The effect of bolus administration of tranexamic acid in revision hip arthroplasty. Hip Int, 22, 2012, 615.
15. 15 Noordin, S., Waters, T.S., Garbuz, D.S., et al. Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty. Clin Orthop Relat Res, 469, 2011, 541.
16. 16 Wei, W., Wei, B., Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty. J Arthroplasty, 29, 2014, 2113.
17. 17 Lakstein, D., Kosashvili, Y., Backstein, D., et al. The long modified extended sliding trochanteric osteotomy. Int Orthop, 35, 2011, 13.
18. 18 Banerjee, S., Issa, K., Kapadia, B.H., et al. Systematic review on outcomes of acetabular revisions with highly-porous metals. Int Orthop, 38, 2014, 689.
19. 19 Kim, Y.Y., Kim, B.J., Ko, H.S., et al. Total hip reconstruction in the anatomically distorted hip. Cemented versus hybrid total hip arthroplasty. Arch Orthop Trauma Surg, 117, 1998, 8.
20. 20 Huang, Z., Ma, J., Shen, B., et al. Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty, 29, 2014, 2342.
21. 21 Lin, S.Y., Chen, C.H., Fu, Y.C., et al. The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. J Arthroplasty, 30, 2015, 776.
22. 22 Konig, G., Hamlin, B.R., Waters, J.H., Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplasty, 28, 2013, 1473.
23. 23 Kwong, L.M., Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis. Orthopedics, 35, 2012, e932.
24. 24 Barnes, C.L., Nelson, C.L., Nix, M.L., et al. Duplex scanning versus venography as a screening examination in total hip arthroplasty patients. Clin Orthop Relat Res(271), 1991, 180.
25. 25 Gross, J.B., Estimating allowable blood loss: corrected for dilution. Anesthesiology, 58, 1983, 277.
26. 26 Liu, X., Zhang, X., Chen, Y., et al. Hidden blood loss after total hip arthroplasty. J Arthroplasty, 26, 2011, 1100.
27. 27 Böhm, P., Bischel, O., Femoral revision with the Wagner SL revision stem: evaluation of one hundred and twenty-nine revisions followed for a mean of 4.8 years. J Bone Joint Surg Am, 83, 2001, 1023.
28. 28 Jansen, A.J., Andreica, S., Claeys, M., et al. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth, 83, 1999, 596.
29. 29 Kassis, J., Hirsh, J., Podor, T.J., Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial celltype I plasminogen activator inhibitor biosynthesis. Blood, 80, 1992, 1758.
30. 30 Iwai, T., Tsuji, S., Tomita, T., et al. Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop, 37, 2013, 441.
31. 31 Horrow, J.C., Van Riper, D.F., Strong, M.D., et al. The dose-response relationship of tranexamic acid. Anesthesiology, 82, 1995, 383.
32. 32 Wong, J., Abrishami, A., El Beheiry, H., et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am, 92, 2010, 2503.
33. 33 Seo, J.G., Moon, Y.W., Park, S.H., et al. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc, 21, 2013, 1869.
34. 34 Gillette, B.P., DeSimone, L.J., Trousdale, R.T., et al. Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res, 471, 2013, 150.
35. 35 Flierl, M.A., Messina, M.J., Mitchell, J.J., et al. Venous thromboembolism prophylaxis after total joint arthroplasty. Orthopedics, 38, 2015, 252.
36. 36 Urquhart, D.M., Hanna, F.S., Brennan, S.L., et al. Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. J Arthroplasty, 25, 2010, 1216.